Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Fry

Blood

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|September 20, 2002
Interleukin 7 worsens graft-versus-host diseaseManoj L Sinha, Terry J Fry, Daniel H Fowler, et al.
Blood|December 15, 2015
Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHDElad Jacoby, Yinmeng Yang, Haiying Qin, et al.
Blood|March 5, 2009
Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effectChristian M Capitini, Sarah Herby, Matthew Milliron, et al.
Blood|July 1, 2004
Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitutionTerry J Fry, Manoj Sinha, Matthew Milliron, et al.
Blood|August 1, 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDChristian M Capitini, Nicole M Nasholm, Christopher D Chien, et al.
Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.
Blood|November 2, 2002
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primatesTerry J Fry, Marcin Moniuszko, Stephen Creekmore, et al.
Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|September 20, 2002
Interleukin 7 worsens graft-versus-host diseaseManoj L Sinha, Terry J Fry, Daniel H Fowler, et al.
Blood|December 15, 2015
Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHDElad Jacoby, Yinmeng Yang, Haiying Qin, et al.
Blood|March 5, 2009
Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effectChristian M Capitini, Sarah Herby, Matthew Milliron, et al.
Blood|July 1, 2004
Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitutionTerry J Fry, Manoj Sinha, Matthew Milliron, et al.
Blood|August 1, 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDChristian M Capitini, Nicole M Nasholm, Christopher D Chien, et al.
Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.
Blood|November 2, 2002
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primatesTerry J Fry, Marcin Moniuszko, Stephen Creekmore, et al.
Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Pageof 2